In our study, we found that a microenvironment with high IL-6 expression in lung cancer was able to activate the JAK2/STAT3 pathway in TAMs, and STAT3, a transcription factor, was able to promote C/EBPβ expression. This evidence concerns the gene IL6 and lung cancer.